About ORCA BIOSYSTEMS, INC
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases, focusing on allogeneic T-cell immunotherapies for high-risk blood cancers such as AML, ALL, and MDS.
Development of high-precision cell therapiesInvestigational allogeneic T-cell immunotherapiesFocus on blood cancers and autoimmune diseases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ORCA BIOSYSTEMS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.